PETRONI, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.823
NA - Nord America 3.847
AS - Asia 2.425
SA - Sud America 293
Continente sconosciuto - Info sul continente non disponibili 101
AF - Africa 65
OC - Oceania 37
Totale 13.591
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 4.162
US - Stati Uniti d'America 3.764
RU - Federazione Russa 919
PL - Polonia 778
SG - Singapore 704
CN - Cina 703
HK - Hong Kong 251
KR - Corea 229
BR - Brasile 225
VN - Vietnam 206
NL - Olanda 186
FR - Francia 134
IE - Irlanda 110
FI - Finlandia 105
GB - Regno Unito 92
SE - Svezia 87
DE - Germania 81
IN - India 64
BD - Bangladesh 62
CA - Canada 50
JO - Giordania 41
CH - Svizzera 39
AT - Austria 38
ID - Indonesia 37
AU - Australia 36
AR - Argentina 26
ES - Italia 20
TR - Turchia 20
JP - Giappone 17
IQ - Iraq 15
MX - Messico 14
PK - Pakistan 13
EC - Ecuador 12
NG - Nigeria 10
ZA - Sudafrica 10
BE - Belgio 9
CZ - Repubblica Ceca 9
PY - Paraguay 9
CI - Costa d'Avorio 8
RO - Romania 8
UA - Ucraina 8
UZ - Uzbekistan 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
EU - Europa 7
AZ - Azerbaigian 6
KE - Kenya 6
KZ - Kazakistan 6
MA - Marocco 6
PH - Filippine 6
TN - Tunisia 6
AL - Albania 5
EG - Egitto 5
GR - Grecia 5
PR - Porto Rico 5
TW - Taiwan 5
BW - Botswana 4
CL - Cile 4
CO - Colombia 4
CR - Costa Rica 4
HR - Croazia 4
IL - Israele 4
JM - Giamaica 4
MY - Malesia 4
BG - Bulgaria 3
BJ - Benin 3
DZ - Algeria 3
HU - Ungheria 3
IR - Iran 3
PE - Perù 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
AO - Angola 2
EE - Estonia 2
KH - Cambogia 2
LT - Lituania 2
LU - Lussemburgo 2
LV - Lettonia 2
MD - Moldavia 2
OM - Oman 2
SV - El Salvador 2
UY - Uruguay 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BY - Bielorussia 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
KG - Kirghizistan 1
MN - Mongolia 1
MQ - Martinica 1
MT - Malta 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
SI - Slovenia 1
SN - Senegal 1
Totale 13.496
Salva come PNG Salva come JPEG
Città #
Santa Clara 873
Warsaw 769
Ashburn 557
Singapore 525
Milan 412
Rome 300
Hefei 242
Seoul 228
Hong Kong 209
Fairfield 202
San Jose 185
Chandler 149
Florence 127
Dublin 106
Houston 104
Beijing 97
Woodbridge 95
Naples 92
Seattle 83
Turin 75
Wilmington 74
Cambridge 72
Moscow 69
Ho Chi Minh City 67
Los Angeles 65
Ann Arbor 64
New York 60
Council Bluffs 59
Helsinki 58
The Dalles 58
Bologna 57
Buffalo 56
Lauterbourg 54
Bari 43
Altamura 40
Lawrence 39
Shanghai 39
Lucca 34
Vienna 34
Hanoi 32
Melbourne 32
Padova 32
Kent 31
Boardman 30
Dallas 30
Princeton 29
Jakarta 28
Mumbai 28
Palermo 28
Livorno 26
Pisa 26
Siena 26
Verona 26
Munich 25
Catania 23
Brescia 22
Cagliari 22
Salerno 21
Venice 20
Lappeenranta 19
Boston 18
Paris 18
São Paulo 18
Trieste 18
Como 17
Tokyo 17
Dong Ket 16
Genoa 16
Perugia 16
Vicenza 16
London 15
Messina 15
Portsmouth 15
Bengaluru 14
Chicago 14
Medford 14
Pescara 14
Toronto 14
Figino 13
Haiphong 13
Modena 13
Novara 12
Turku 12
West Jordan 12
Parma 11
Reggio Emilia 11
Abuja 10
Casalecchio di Reno 10
Duncan 10
Ferrara 10
Frankfurt am Main 10
Prato 10
San Francisco 10
Orem 9
San Diego 9
Vimercate 9
Zurich 9
Abidjan 8
Amsterdam 8
Ancona 8
Totale 7.540
Salva come PNG Salva come JPEG
Nome #
Immunogenicità dei Farmaci Biologici: Analisi dei Meccanismi Fisiopatologici e Sviluppo di Test in vitro per il suo Monitoraggio 4.400
The conformational state of hERG1 channels determines integrin association, downstream signaling, and cancer progression 446
A novel allergen-adjuvant conjugate suitable for specific immunotherapy of respiratory allergy 386
Treatment with 8-OH-modified adenine (TLR7 ligand)-allergen conjugates decreases T helper type 2-oriented murine airway inflammation 364
HERG1 positivity and Glut-1 negativity identifies high-risk TNM stage I and II colorectal cancer patients, regardless of adjuvant chemotherapy 341
hERG1 and HIF-2α Behave as Biomarkers of Positive Response to Bevacizumab in Metastatic Colorectal Cancer Patients 258
New gold carbene complexes as candidate anticancer agents 241
Data describing the effects of the Macrolide Antibiotic Clarithromycin on preclinical mouse models of Colorectal Cancer 228
Anticancer effects against colorectal cancer models of chloro(triethylphosphine)gold(I) encapsulated in PLGA–PEG nanoparticles 220
The combined activation of K Ca 3.1 and inhibition of K v 11.1/hERG1 currents contribute to overcome Cisplatin resistance in colorectal cancer cells 220
Challenges in the treatment of small cell lung cancer in the era of immunotherapy and molecular classification 216
Potassium and Sodium Channels and the Warburg Effect: Biophysical Regulation of Cancer Metabolism 213
Chlorido and bromido oxaliplatin analogues as potential agents for CRC treatment: Solution behavior, protein binding and cytotoxicity evaluation 202
Assays and strategies for immunogenicity assessment of biological agents. 200
Peptides and small molecules blocking the CXCR4/CXCL12 axis overcome bone marrow-induced chemoresistance in acute leukemias 190
Drug-Specific Th2 Cells and IgE Antibodies in a Patient with Anaphylaxis to Rituximab 188
A novel nDer p2-conjugated TLR7 down-modulates Th2-associated lung inflammation by using a therapeutical protocol 186
Clarithromycin inhibits autophagy in colorectal cancer by regulating the hERG1 potassium channel interaction with PI3K 177
Cellular senescence in the response of HR+ breast cancer to radiotherapy and CDK4/6 inhibitors 174
Manifestations of Antidrug Antibodies Response: Hypersensitivity and Infusion Reactions. 171
Autophagy in major human diseases 167
Immunofluorescence microscopy-based assessment of cytosolic DNA accumulation in mammalian cells 164
Caspase 2 and p53 Reunited in Tumor Control 157
Deciphering the Renal tumOr microenvironment to PersonaLize immunE-targeted Treatment (DROPLET): transcriptomic profiling of primary and secondary lesions identified a potential crosstalk between MARCO+ macrophages and deregulated cancer-cell proliferation in mediating progression and therapy response of advanced renal cell carcinoта. 156
Exploiting Tertiary Lymphoid Structures to Stimulate Antitumor Immunity and Improve Immunotherapy Efficacy 156
Noncanonical Cell Fate Regulation by Bcl-2 Proteins 155
Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer 154
Quantification of cytosolic DNA species by immunofluorescence microscopy and automated image analysis 151
Apoptotic caspases inhibit abscopal responses to radiation and identify a new prognostic biomarker for breast cancer patients 148
Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy 148
Immunomodulation by targeted anticancer agents 144
Ion Channel Conformations Regulate Integrin-Dependent Signaling 142
MPA/DMBA-driven mammary carcinomas 141
Impact of treatment schedule on the efficacy of cytostatic and immunostimulatory agents 140
Allergological in vitro and in vivo evaluation of patients with hypersensitivity reactions to infliximab. 139
Senescence Inflames the Pancreatic Tumor Microenvironment 135
Circulating T cells to infliximab are detectable mainly in treated patients developing anti-drug antibodies and hypersensitivity reactions 135
Early changes in circulating tumor DNA (ctDNA) predict treatment response in metastatic KRAS-mutated colorectal cancer (mCRC) patients 134
Cancer Immunotherapy with CDK7 Inhibitors 133
Poly(I:C) promotes the production of IL-17A by murine CD1d-driven invariant NKT cells in airway inflammation. 132
Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER+ Breast Cancer 131
Short and long-term effect of a novel nDer p2-conjugated TLR7 ligand in the prevention of allergic lung inflammation 129
RT-PCR-assisted quantification of type I IFN responses in irradiated cancer cells 127
NK cells beat T cells at early breast cancer control 125
Immunogenicity of cell death driven by immune effectors 123
Cytofluorometric assessment of cell cycle progression in irradiated cells 123
Immunomodulation by anticancer cell cycle inhibitors 120
Immunogenicity of Biological Agents: Basic Knowledge and Clinical Implications 116
Immunogenic Therapies Drive CAR T Cells towards Superior Efficacy 113
Targeting oncogene and non-oncogene addiction to inflame the tumour microenvironment 107
Targeting potassium channels and autophagy to defeat chemoresistance 90
Unconventional strategy could be the future: From target to KRAS broad range treatment 82
KRAS G12C inhibition enhances efficacy to conventional chemotherapy in KRAS-mutant NSCLC 60
Metabolomics Plasma Biomarkers Associated with the HRD Phenotype in Ovarian Cancer 46
Th17-like cells and immunosuppressive macrophages infiltrate tertiary lymphoid structures with distinct maturation status in soft-tissue sarcoma 41
CYPD limits HR+ mammary carcinogenesis in mice 25
Microbiome dysbiosis and KRAS-driven tumorigenesis in pancreatic cancer: implications for immune checkpoint inhibitors efficacy 23
Impact of radiation therapy dose, fractionation, and immunotherapeutic partner in a mouse model of hormone receptor–positive mammary carcinogenesis 23
IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2− breast cancer via CX3CR1+ macrophages 19
An immunological mechanism of resistance to CDK4/6 inhibitors in HR+ breast cancer 16
Totale 13.591
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.203
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.203
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022433 0 34 35 27 41 26 36 42 23 46 41 82
2022/20231.269 72 153 68 77 94 132 104 113 143 78 113 122
2023/20241.426 90 67 140 88 118 194 151 225 64 107 90 92
2024/20253.609 154 292 242 528 846 534 61 177 246 116 165 248
2025/20264.082 440 548 499 350 357 138 451 186 255 265 199 394
2026/2027188 167 21 0 0 0 0 0 0 0 0 0 0
Totale 13.591